ANIMAL HEALTH SECTOR

CPH expands its footprint with new product launch and entry into Eastern Europe

Finfeed Archived May 21, 2021

Creso Pharma (ASX: CPH) will enter the Polish animal health market after signing a Letter of Intent with Polvet Healthcare Teodorowski Spółka Jawna. It has also finalised the development of anibidiol® swine, a new and innovative hemp flour and oat bran based complementary feed product.

CPH Confirms US Cannabis Market Entry with Established Partner - US$5M Sales Target

Next Investors Mar 01, 2021

Creso Pharma (ASX: CPH | FRA: 1X8) is set to distribute its range of CBD and hemp animal health anibidiol® products throughout the US, following a deal signed with CERES Natural Remedies.

Creso up 50% in a week with further catalysts imminent

Finfeed Archived Dec 02, 2020

Creso Pharma (ASX: CPH) has received three new purchase orders totalling $414,000 for its anibidiol® line of animal health products.

Animal Health Sector

CPH expands its footprint with new product launch and entry into Eastern Europe

CPH Confirms US Cannabis Market Entry with Established Partner - US$5M Sales Target

Creso up 50% in a week with further catalysts imminent